Services
Online Inquiry

For research use only. Not intended for any clinical use.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Non-Human Primate (NHP) Metabolite Identification & Reaction Phenotyping Assay Service

Are you currently facing challenges with translational research, unpredictable drug metabolism in human trials, or the need to de-risk your lead candidates? Creative Biolabs' Non-Human Primate Metabolite Identification & Reaction Phenotyping Assay helps you overcome these hurdles by providing a deep understanding of your compound's metabolic profile in a highly relevant model. We utilize cutting-edge mass spectrometry and bioanalytical expertise to ensure your project advances with clarity and precision.

Introduction of NHP Metabolite Identification & Reaction Phenotyping Assay

NHPs are the gold standard for preclinical drug metabolism and pharmacokinetic (DMPK) studies due to their high genetic and immunological similarities to humans. This close biological relationship makes NHPs an indispensable model for bridging the gap between early discovery and clinical development, providing a more reliable prediction of human drug behavior compared to other species. Creative Biolabs leverages these biological advantages to provide critical insights into how your compound is metabolized before it enters human trials.

What Our Service Is

This service is a specialized bioanalytical assay designed to meticulously identify and characterize the metabolites of your drug candidate in NHP samples, and to pinpoint the specific enzymes responsible for their formation.

  • De-risking Lead Candidates. By identifying key metabolites and their formation pathways, we help you assess potential toxicity risks early in the development pipeline, allowing you to select the most promising compounds for further investment.
  • Investigating Drug-Drug Interactions (DDIs). We can determine which enzymes metabolize your drug, helping to predict and mitigate the risk of adverse drug-drug interactions when co-administered with other therapies.

Why Choose Us?

Navigating the complexities of drug metabolism can lead to unexpected delays and costly failures in later development stages. Creative Biolabs creates value for our clients by transforming this pain point into a clear benefit. We provide high-quality, actionable data that reduces uncertainty, mitigates risk, and accelerates your project timeline. Our robust assay streamlines the discovery-to-development continuum, ensuring a seamless transition to clinical trials.

Overlapping patterns of metabolite abundance in the three NHP study groups across different tissue types. (OA Literature)Fig.1 Comparative patterns of metabolite abundance in the three NHP study groups across various tissue types.1

Key Benefits of Our Service

At Creative Biolabs, our Non-Human Primate Metabolite Identification & Reaction Phenotyping Assay offers unparalleled advantages that set your project up for success.

  • Exceptional Response Speed: We understand the time-sensitive nature of drug development. Our optimized workflow and dedicated team ensure rapid turnaround times, delivering critical data back to you when you need it most, without compromising on quality.
  • Unmatched NHP Resources: We maintain access to a carefully managed, high-quality non-human primate colony. This allows us to select the most appropriate animal models for your study, ensuring the relevance and reliability of your results.
  • Customization to Your Project Needs: Every molecule is unique. We offer highly customizable assay protocols tailored to the specific characteristics of your compound and the goals of your study. Whether you need to investigate a single metabolite or a complete metabolic profile, we design a solution that fits.
  • Comprehensive Reporting Depth: Our deliverables go beyond simple data. We provide in-depth, annotated reports that include clear data visualizations, interpretation of findings, and direct links to the underlying raw data. This level of detail is designed to be directly usable for your internal decision-making and regulatory submissions.

How Creative Biolabs' Assays Can Assist Your Project?

Creative Biolabs' NHP Metabolite Identification & Reaction Phenotyping Assay provides a clear, actionable solution to the critical challenge of understanding a compound's metabolic fate. Our service delivers a detailed blueprint of how your drug is processed by the body, offering a tangible solution to potential translational issues before they become a major roadblock.

Workflow

01

Required Starting Materials

02

Project Consultation & Protocol Design

03

In Vivo Study and Sample Collection

04

Data Processing & Metabolite Identification

05

Reaction Phenotyping

06

Final Reporting

Key Deliverables

  • Final Study Report: A comprehensive, publication-ready report with detailed methodology, results, and a summary of key findings.
  • Raw Data Files: All raw LC-MS/MS data and mass spectra for your records.
  • Annotated Metabolite List: A detailed table of all identified metabolites, their corresponding metabolic pathways, and the specific enzymes responsible for their formation.
  • Enzyme Reaction Phenotyping Data: A clear summary of the enzymes involved in the metabolism of your compound.

Capabilities & Partnerships

Service-Specific Data

  • Annual Sample Size: Over 50,000 compounds
  • Typical Turnaround Time (TAT): 10-15 business days
  • Assay Pass Rate: >98%

Our Valued Partners

Frequently Asked Questions

Q: Why do I need a specialized NHP assay?
A: The NHP model offers a more physiologically relevant system that can reveal complex metabolic pathways, circulating metabolites, and potential toxicities that may not be apparent in a test tube. Our service bridges this gap, providing confidence before you commit to human trials.
Q: How do you handle a drug that is metabolized by multiple enzymes?
A: Our reaction phenotyping service is specifically designed to handle this complexity. We meticulously test the parent compound against a panel of recombinant enzymes to precisely determine the contribution of each enzyme to the overall metabolic profile, providing a clear picture of the metabolic pathways.
Q: My compound is very new. Can you still help with an unknown metabolic profile?
A: Absolutely. Our assay and bioinformatic pipelines are designed for the de novo identification of both known and unknown metabolites. We use high-resolution mass spectrometry to capture even low-abundance species, ensuring a thorough characterization of your compound's metabolic fate.
Q: What if I have specific questions about the results or need to re-evaluate the data later?
A: Our commitment to you doesn't end with the report. We provide comprehensive post-study consultation and are always available to help you interpret the results, answer your questions, and discuss any potential next steps.
Q: What is the first step to get started with this service?
A: The best way to begin is to contact our scientific team for a free consultation. We'll discuss your project goals and help you design the most effective and cost-efficient study protocol to meet your needs.

Contact Us

Creative Biolabs is your trusted partner for NHP Metabolite Identification & Reaction Phenotyping. Our expertise, advanced technology, and client-focused approach are designed to help you de-risk your drug candidate and accelerate your path to market. To learn more about our services or to discuss your specific project needs, please contact our team. We look forward to partnering with you on your next breakthrough.

Reference

  1. Cheema, Amrita K., et al. "Metabolomic studies of tissue injury in nonhuman primates exposed to gamma-radiation." International journal of molecular sciences 20.13 (2019). Distributed under Open Access license CC BY 4.0, without modification. DOI: https://doi.org/10.3390/ijms20133360
Cart
Cart